• What We Do
  • Your Experience
  • Protocols
  • Science
  • Team

Scientific Advisory Board

Dr. Dale Bredesen, MD

Neurologist

Dr. Dobri Kiprov, M.D., H.P. (ASCP)

Chief Medical Officer of Clarify Clinics, Chief Medical Officer of Marker Therapeutics, Immunologist

Dr. Joseph (Yossi) Schwartz, MD, MPH

Hematologist

Dr. Muharrem Yunce, MD.

Pathologist

Executive Team

Prof. Antonio Belli, MBChB

Director and Medical Advisor to Clarify Clinics, Chief Medical Officer of Marker Diagnostics, Neurosurgeon

David Cohen, B.Sc Chem Eng., MBA

Director, Chairman and CEO of Marker AG

Yael Cohen

Chief Executive Officer of Clarify Clinics

Tinus Maree, BLC, LLB.

Director and General Counsel of Marker AG and Clarify Clinics

Regulatory Team

Marilyne Joly, B.Sc, M.Sc., LLB.

Vice President of Regulatory Affairs

Christopher McLean, M.Eng., B.Eng.

Regulatory Affairs Specialist

Dr. Jean Michel-Lacroix, B.Sc., M.Sc., Ph.D.

Director of Quality Assurance

Randy Wenthold, B.Sc Chem Eng.

Vice President of Operations

Thought Partners

Dr. Matt Cook, MD, FAARM, ABAARM

Regenerative Medicine

Dr. Adeel Khan, MD

Regenerative Medicine

Dr. Frank Lipman, MD

Alternative and Functional Medicine

Dr. David Perlmutter, MD, FACN

Neurologist

Serena Poon, CN, CHC, CHN

Longevity and Holistic Wellness Specialist

Dr. Elizabeth Yurth, MD, ABPMR, ABAARM, FAARM, FAARFM, FSSRP

Regenerative Medicine

London
Clarify Clinics at UNTIL
1 Orchard St
London W1H 6HJ, UK
Google Map

Dubai
Clarify Clinics at Al Moosa Health
Villa #3 Al Wasl Rd, Jumeriah 1
Dubai, UAE (Between 5B and 3rd Street on Al Wasl Road)
Google Map

Johannesburg
Clarify Clinics at Optimum Healthspan Institute (OHI)
Block B, 150 Linden Road
Sandton, Johannesburg
Google Map

info@clarifyclinics.com

+44 20 7099 2911

  • What We Do
  • Your Experience
  • Protocols
  • Science
  • Team
  • FAQ
  • Contact Us
  • Stay Updated
  • Terms & Conditions
  • Privacy Policy

The CE mark signifies a medical device's compliance with EU and UK safety standards, allowing its legal sale and use in the European Economic Area and the UK.